Nida Khan in TCS Nashik case: Designation disputed, pregnancy cited for bail, police deploy four teams in ongoing manhunt
Fresnillo (LSE: FRES): Can the world’s largest silver miner hold its record gains as 2026 output dips?
TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record
Read More Pharma Industry News Can this A$653m raise turn PYC Therapeutics (ASX: PYC) into a global RNA frontrunner? PYC Therapeutics is raising A$653M to fund four RNA therapies into human efficacy trials. Find out what this means for investors and the biotech sector. bySrinathFebruary 2, 2026